drugset / Trial / NCT02089841

Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria.

NCT02089841

Phase 4 Completed 140 enrolled Richard Mwaiswelo Karolinska Institutet · collab
NaSingle-groupOpen-labelTreatment

Summary

Artemether-lumefantrine has been used in Tanzania as first-line treatment for uncomplicated malaria since 2007. Nonetheless, a report of increased proportion of patients with parasitaemia on day 1 following treatment with artemisinin based combination therapies has emerged from Kenya. Similarly, resistance against artemisinins has been confirmed in South-East Asia and it can spread to Africa. Therefore, the purpose of this study was to assess the efficacy of Artemether-lumefantrine for the treatment of uncomplicated malaria among children after five years of wide scale use of the drug in Tanzania.

Timeline

Start
2012-05
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Artemether-lumefantrine Unknown